Investigational Site Number :6430020

Moscow 125284

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Non-relapsing Secondary Progressive Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early